'O', erythropoietin carbamoylation versus carbamylation

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 3033-

  Jelkmann, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMIC ACID; CARBON DIOXIDE; CYANIC ACID; HOMOCITRULLINE; LYSINE; RECOMBINANT ERYTHROPOIETIN; UREA;

CARBAMOYLATION; CHRONIC KIDNEY DISEASE; KIDNEY INJURY; LETTER; PRIORITY JOURNAL; PROTEIN INTERACTION; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

CITRULLINE; EPOETIN ALFA; ERYTHROPOIETIN; KIDNEY; KIDNEY TUBULES; TERMINOLOGY AS TOPIC; URETERAL OBSTRUCTION;

EID: 58549098542     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn342     Document Type: Letter

References (5)

1. Kitamura H, Isaka Y, Takabatake Y et al. Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model. Nephrol Dial Transplant 2008; 23: 152-1528
2. Leist M, Ghezzi P, Grasso G et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305: 239-242
3. Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000; 80: 681-715
4. Galle J, Wanner Ch. Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation. Miner Electrolyte Metab 1999; 25: 263-268
5. Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 2001; 78: S102-S10